Ad is loading...
DHPYX
Price
$19.24
Change
+$0.21 (+1.10%)
Updated
Nov 22 closing price
JVMRX
Price
$32.27
Change
+$0.32 (+1.00%)
Updated
Nov 22 closing price
Ad is loading...

DHPYX vs JVMRX

Header iconDHPYX vs JVMRX Comparison
Open Charts DHPYX vs JVMRXBanner chart's image
Diamond Hill Mid Cap Y
Price$19.24
Change+$0.21 (+1.10%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap R6
Price$32.27
Change+$0.32 (+1.00%)
VolumeN/A
CapitalizationN/A
DHPYX vs JVMRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DHPYX vs. JVMRX commentary
Nov 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHPYX is a Buy and JVMRX is a Buy.

FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 24.4B vs. DHPYX (155M). DHPYX pays higher dividends than JVMRX: DHPYX (1.12) vs JVMRX (0.93). DHPYX was incepted earlier than JVMRX: DHPYX (11 years) vs JVMRX (13 years). JVMRX is a more actively managed with annual turnover of: 41.00 vs. DHPYX (22.00). DHPYX has a lower initial minimum investment than JVMRX: DHPYX (500000) vs JVMRX (1000000). DHPYX annual gain was more profitable for investors over the last year : 26.58 vs. JVMRX (23.45). JVMRX return over 5 years is better than : 50.16 vs. DHPYX (38.74).
DHPYXJVMRXDHPYX / JVMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years13 years-
Gain YTD17.38917.94697%
Front LoadN/AN/A-
Min. Initial Investment500000100000050%
Min. Initial Investment IRAN/AN/A-
Net Assets155M24.4B1%
Annual Yield % from dividends1.120.93120%
Returns for 1 year26.5823.45113%
Returns for 3 years5.3811.6346%
Returns for 5 years38.7450.1677%
Returns for 10 years93.9266.48141%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRT30.641.04
+3.51%
Karat Packaging
AOUT9.790.21
+2.19%
American Outdoor Brands
RGEN142.580.82
+0.58%
Repligen Corp
TNDM30.810.07
+0.23%
Tandem Diabetes Care
ARTL1.11-0.02
-1.77%
Artelo Biosciences